Artificial ventilation setting in patients infected with COVID-19
- Conditions
- Respiratory tract diseasesVirus diseasesRespiratory Distress Syndrome, AdultC08.381.840
- Registration Number
- RBR-2z3f7k
- Lead Sponsor
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Age 18 to 80 years; Mechanically ventilated patients with COVID-19 infection suspicious
Pregnancy confirmed by laboratory tests;
• Weight below 35 kg; Patients undergoing endotracheal intubation as a result of exacerbation of chronic lung disease; Radiological aspects compatible with pulmonary fibrosis, consolidation of the lung parenchyma, tumor masses and emphysema; Patients with pneumatocele; Pneumothorax, subcutaneous emphysema and pneumomediastinum documented and not resolved; Patients with heart failure previously classified as functional class III or IV according to the New York Heart Association (NYHA); Patients with acute coronary syndrome or persistent ventricular tachyarrhythmias; Mean arterial pressure (MAP) less than 65 mmHg with a dose of norepinephrine 0.5 to 1.0 mg / kg / min; Acute brain injury or high intracranial pressure, that is, greater than 18 mmHg;
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of mechanical parameters between table adjustment and decremental titration<br>
- Secondary Outcome Measures
Name Time Method To evaluate the effects of individualized PEEP adjustment on gas exchange in patients with ARDS infected with COVID-19.<br><br>;Time of mechanical ventilation;Incidence of pneumothorax;Intrahospital mortality